Terms: = Ovarian cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
42 results:
1. Do statins play any role in reducing the incidence and mortality of ovarian cancer? A systematic review and meta-analysis.
Mohammadian-Hafshejani A; Sherwin CMT; Heidari-Soureshjani S
J Prev Med Hyg; 2020 Sep; 61(3):E331-E339. PubMed ID: 33150223
[TBL] [Abstract] [Full Text] [Related]
2. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Mavaddat N; Antoniou AC; Mooij TM; Hooning MJ; Heemskerk-Gerritsen BA; ; Noguès C; Gauthier-Villars M; Caron O; Gesta P; Pujol P; Lortholary A; ; Barrowdale D; Frost D; Evans DG; Izatt L; Adlard J; Eeles R; Brewer C; Tischkowitz M; Henderson A; Cook J; Eccles D; ; van Engelen K; Mourits MJE; Ausems MGEM; Koppert LB; Hopper JL; John EM; Chung WK; Andrulis IL; Daly MB; Buys SS; ; Benitez J; Caldes T; Jakubowska A; Simard J; Singer CF; Tan Y; Olah E; Navratilova M; Foretova L; Gerdes AM; Roos-Blom MJ; Van Leeuwen FE; Arver B; Olsson H; Schmutzler RK; Engel C; Kast K; Phillips KA; Terry MB; Milne RL; Goldgar DE; Rookus MA; Andrieu N; Easton DF; ; ;
Breast Cancer Res; 2020 Jan; 22(1):8. PubMed ID: 31948486
[TBL] [Abstract] [Full Text] [Related]
3. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract] [Full Text] [Related]
4. Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression.
Agostini A; Brunetti M; Davidson B; Tropé CG; Heim S; Panagopoulos I; Micci F
Oncotarget; 2017 Mar; 8(13):21554-21560. PubMed ID: 28423547
[TBL] [Abstract] [Full Text] [Related]
5. Histopathology Discrepancy of Preoperative Endometrial Sampling and Final Specimen: How Does This Influence Selective Lymph Node Dissection?
Corr BR; Carrubba A; Sheeder J; Cheng G; Guntupalli SR
Int J Gynecol Cancer; 2017 Feb; 27(2):297-301. PubMed ID: 27870710
[TBL] [Abstract] [Full Text] [Related]
6. fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
[TBL] [Abstract] [Full Text] [Related]
7. The impact of qualitative research on gynaecologic oncology guidelines.
How JA; Abitbol J; Lau S; Gotlieb WH; Abenhaim HA
J Obstet Gynaecol Can; 2015 Feb; 37(2):138-144. PubMed ID: 25767946
[TBL] [Abstract] [Full Text] [Related]
8. Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations.
Huang HN; Huang WC; Lin CH; Chiang YC; Huang HY; Kuo KT
Hum Pathol; 2014 Nov; 45(11):2318-25. PubMed ID: 25281027
[TBL] [Abstract] [Full Text] [Related]
9. Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases.
Virzì S; Iusco D; Baratti D; Bonomi S; Grassi A; Kusamura S; Deraco M
Tumori; 2013; 99(5):589-95. PubMed ID: 24362862
[TBL] [Abstract] [Full Text] [Related]
10. Genetic alterations of the WWOX gene in breast cancer.
Ekizoglu S; Muslumanoglu M; Dalay N; Buyru N
Med Oncol; 2012 Sep; 29(3):1529-35. PubMed ID: 21983861
[TBL] [Abstract] [Full Text] [Related]
11. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
[TBL] [Abstract] [Full Text] [Related]
12. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
Guler G; Himmetoglu C; Jimenez RE; Geyer SM; Wang WP; Costinean S; Pilarski RT; Morrison C; Suren D; Liu J; Chen J; Kamal J; Shapiro CL; Huebner K
Breast Cancer Res Treat; 2011 Sep; 129(2):421-32. PubMed ID: 21069451
[TBL] [Abstract] [Full Text] [Related]
13. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
[TBL] [Abstract] [Full Text] [Related]
14. [Promoter hypermethylation gene patterns in gynecological tumors].
Leal Rojas P; Anabalón Rodríguez L; García Muñoz P; Tapia Escalona O; Guzmán González P; Araya Orostica JC; Villaseca Hernández M; Roa Strauch JC
Med Clin (Barc); 2009 Mar; 132(10):371-6. PubMed ID: 19268989
[TBL] [Abstract] [Full Text] [Related]
15. Non-random inactivation of large common fragile site genes in different cancers.
McAvoy S; Ganapathiraju SC; Ducharme-Smith AL; Pritchett JR; Kosari F; Perez DS; Zhu Y; James CD; Smith DI
Cytogenet Genome Res; 2007; 118(2-4):260-9. PubMed ID: 18000379
[TBL] [Abstract] [Full Text] [Related]
16. Lack of association of fragile histidine triad (fhit) polymorphisms with lung cancer in the Korean population.
Jung HY; Sung JS; Whang YM; Shin HD; Park BL; Kim JS; Shin SW; Seo HY; Sung HJ; Choi IK; Oh SC; Seo JH; Kim YH
J Hum Genet; 2007; 52(8):668. PubMed ID: 17609851
[TBL] [Abstract] [Full Text] [Related]
17. fhit-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells.
Bianchi F; Magnifico A; Olgiati C; Zanesi N; Pekarsky Y; Tagliabue E; Croce CM; Ménard S; Campiglio M
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):18981-6. PubMed ID: 17142325
[TBL] [Abstract] [Full Text] [Related]
18. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
[TBL] [Abstract] [Full Text] [Related]
19. Common fragile sites, extremely large genes, neural development and cancer.
Smith DI; Zhu Y; McAvoy S; Kuhn R
Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
[TBL] [Abstract] [Full Text] [Related]
20. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
Hong FZ; Wang B; Li HM; Liew CT
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
[TBL] [Abstract] [Full Text] [Related]
[Next]